Table 6.
Smaller Decrement in TRR After Recovery of Symptoms Correlates With Lower Higher MRDR in Children With URI, but Without Wheezing
MRDR | TRR (R5Hz* , †) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Symptomatic phase | Post‐recovery | P‐value | |||||||
n | % subjects | TRR (mean ± SD) | % predicted TRR | n | % subjects | TRR (mean ± SD) | % predicted TRR | ||
>0.060 | 40 | 58.0 | 1.14 ± 0.22 | 96.0 ± 18.2 | 39 | 58.2 | 1.15 ± 0.21 | 96.3 ± 16.9 | 0.565 |
0.030–0.060 | 9 | 13.0 | 1.17 ± 0.16 | 98.8 ± 11.0 | 9 | 13.4 | 1.04 ± 0.09 | 86.5 ± 6.2 | 0.020 |
<0.030 | 20 | 29.0 | 1.15 ± 0.17 | 99.1 ± 16.0 | 19 | 28.3 | 1.05 ± 0.16 | 88.2 ± 15.0 | 0.003 |
Total | 69 | 100.0 | 67 | 100.0 |
Mean ± SD.
Two‐way repeated measure ANOVA on ranks showed a significant difference between the symptomatic and post‐recovery measurements when the MRDR was between 0.030–0.060 and <0.03.
Mean ± SEM.